Matthew Strobeck - Net Worth and Insider Trading
Matthew Strobeck Net Worth
The estimated net worth of Matthew Strobeck is at least $4 Million dollars as of 2025-07-09. Matthew Strobeck is the Director of QuidelOrtho Corp and owns about 62,174 shares of QuidelOrtho Corp (QDEL) stock worth over $2 Million. Matthew Strobeck is the Director of Biodesix Inc and owns about 5,399,148 shares of Biodesix Inc (BDSX) stock worth over $2 Million. Matthew Strobeck is also the Director of Accelerate Diagnostics Inc and owns about 219,380 shares of Accelerate Diagnostics Inc (AXDXQ) stock worth over $1,229. Details can be seen in Matthew Strobeck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Strobeck has not made any transactions after 2024-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Strobeck
Matthew Strobeck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Strobeck owns 5 companies in total, including QuidelOrtho Corp (QDEL) , Accelerate Diagnostics Inc (AXDXQ) , and Yield10 Bioscience Inc (YTENQ) among others .
Click here to see the complete history of Matthew Strobeck’s form 4 insider trades.
Insider Ownership Summary of Matthew Strobeck
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| QDEL | QuidelOrtho Corp | 2022-05-27 | director |
| AXDXQ | Accelerate Diagnostics Inc | 2021-02-19 | director |
| YTENQ | Yield10 Bioscience Inc | 2015-09-10 | director |
 | | 2024-11-05 | director |
| | 2021-12-05 | 10 percent owner |
Matthew Strobeck Latest Holdings Summary
Matthew Strobeck currently owns a total of 3 stocks. Among these stocks, Matthew Strobeck owns 62,174 shares of QuidelOrtho Corp (QDEL) as of September 3, 2020, with a value of $2 Million and a weighting of 54.67%. Matthew Strobeck owns 5,399,148 shares of Biodesix Inc (BDSX) as of November 5, 2024, with a value of $2 Million and a weighting of 45.29%. Matthew Strobeck also owns 219,380 shares of Accelerate Diagnostics Inc (AXDXQ) as of March 18, 2020, with a value of $1,229 and a weighting of 0.04%.
Latest Holdings of Matthew Strobeck
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QDEL | QuidelOrtho Corp | 2020-09-03 | 62,174 | 30.82 | 1,916,203 |
| BDSX | Biodesix Inc | 2024-11-05 | 5,399,148 | 0.29 | 1,587,350 |
| AXDXQ | Accelerate Diagnostics Inc | 2020-03-18 | 219,380 | 0.01 | 1,229 |
Holding Weightings of Matthew Strobeck
Matthew Strobeck Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Strobeck has made a total of 1 transactions in QuidelOrtho Corp (QDEL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in QuidelOrtho Corp is the acquisition of 7,700 shares on September 3, 2020, which cost Matthew Strobeck around $1 Million.
According to the SEC Form 4 filings, Matthew Strobeck has made a total of 4 transactions in Biodesix Inc (BDSX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Biodesix Inc is the acquisition of 40,000 shares on November 5, 2024, which cost Matthew Strobeck around $56,000.
According to the SEC Form 4 filings, Matthew Strobeck has made a total of 0 transactions in Accelerate Diagnostics Inc (AXDXQ) over the past 5 years. The most-recent trade in Accelerate Diagnostics Inc is the acquisition of 1,000 shares on March 18, 2020, which cost Matthew Strobeck around $71,100.
Insider Trading History of Matthew Strobeck
- 1
Matthew Strobeck Trading Performance
GuruFocus tracks the stock performance after each of Matthew Strobeck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Strobeck is 28.2%. GuruFocus also compares Matthew Strobeck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Strobeck within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Strobeck's insider trading performs compared to the benchmark.
Performance of Matthew Strobeck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.16 | | | | | |
| Relative Return to S&P 500(%) | 15.84 | | | | | |
Matthew Strobeck Ownership Network
Ownership Network List of Matthew Strobeck
Ownership Network Relation of Matthew Strobeck
Matthew Strobeck Owned Company Details
What does QuidelOrtho Corp do?
Who are the key executives at QuidelOrtho Corp?
Matthew Strobeck is the director of QuidelOrtho Corp. Other key executives at QuidelOrtho Corp include 10 percent owner Carlyle Group Inc. , Chief Financial Officer Joseph M Busky , and SVP & Chief Information Officer Louise Brandy .
QuidelOrtho Corp (QDEL) Insider Trades Summary
Over the past 18 months, Matthew Strobeck made no insider transaction in QuidelOrtho Corp (QDEL). Other recent insider transactions involving QuidelOrtho Corp (QDEL) include a net sale of 12,460,183 shares made by Carlyle Group Inc. , a net purchase of 6,033 shares made by Brian J Blaser , and a net purchase of 2,150 shares made by Joseph M Busky .
In summary, during the past 3 months, insiders sold 0 shares of QuidelOrtho Corp (QDEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,460,183 shares of QuidelOrtho Corp (QDEL) were sold and 8,183 shares were bought by its insiders, resulting in a net sale of 12,452,000 shares.
QuidelOrtho Corp (QDEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
QuidelOrtho Corp Insider Transactions
Matthew Strobeck Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Strobeck. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Strobeck's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
